TR201205320A2 - Galantamin formülasyonları ve üretim yöntemi. - Google Patents

Galantamin formülasyonları ve üretim yöntemi.

Info

Publication number
TR201205320A2
TR201205320A2 TR2012/05320A TR201205320A TR201205320A2 TR 201205320 A2 TR201205320 A2 TR 201205320A2 TR 2012/05320 A TR2012/05320 A TR 2012/05320A TR 201205320 A TR201205320 A TR 201205320A TR 201205320 A2 TR201205320 A2 TR 201205320A2
Authority
TR
Turkey
Prior art keywords
production method
formulations
galantamine
mild
symptomatic treatment
Prior art date
Application number
TR2012/05320A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TR2012/04568A external-priority patent/TR201204568A2/tr
Application filed by Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi filed Critical Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Publication of TR201205320A2 publication Critical patent/TR201205320A2/tr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş hafif ve orta şiddetli Alzheimer tipi demansın semptomatik tedavisinde ve serebrovasküler hastalık ile ilişkili hafif ve orta derecede şiddetli Alzheimer tipi demansın semptomatik tedavisinde kullanılmak üzere galantamin veya farmasötik olarak kabul edilebilir bir tuzunu içeren farmasötik formülasyonlar ve bu formülasyonların üretim yöntemine ilişkindir.
TR2012/05320A 2012-04-19 2012-05-08 Galantamin formülasyonları ve üretim yöntemi. TR201205320A2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2012/04568A TR201204568A2 (tr) 2012-04-19 2012-04-19 Galantamin içeren efervesan tablet.
TR201205004 2012-04-19

Publications (1)

Publication Number Publication Date
TR201205320A2 true TR201205320A2 (tr) 2013-11-21

Family

ID=67911013

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2012/05320A TR201205320A2 (tr) 2012-04-19 2012-05-08 Galantamin formülasyonları ve üretim yöntemi.

Country Status (1)

Country Link
TR (1) TR201205320A2 (tr)

Similar Documents

Publication Publication Date Title
ZA202202711B (en) Sustained-release dosage forms of ruxolitinib
CY1122730T1 (el) 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων
BR112015020466A8 (pt) inibidores de cdc7, seus usos, e composição farmacêutica
CL2014001752A1 (es) Compuestos biciclicos sustituidos; composicion farmaceutica que los comprende; y uso en el tratamiento de enfermedades tales como cancer, alzheimer, sida, entre otras.
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
CL2017002781A1 (es) Métodos de tratamiento de enfermedad de alzheimer
MA44637B1 (fr) Composes hétérocycliques et leurs utilisations
MX370611B (es) Metodos utiles en la sintesis de analogos de halicondrina b.
PE20141792A1 (es) Formas polimorficas de (s)-2-(1-(9h-purin-6-ilamino)propil)-5-fluor-3-fenilquinazolin-4(3h)-ona
NZ725131A (en) Tubulysin derivatives
GR1008233B (el) Βελτιωση και θεραπευτικη αξιοποιηση της συμπτωματικης αντιμετωπισης της ασθενειας του alzheimer με rivastigmine, galantamine ή donepezil, δια επιλεγμενων αμινοτετραϋδροφουρανιων που δρουν σαν μικτοι σιγμα-1/ μουσκαρινικοι προσδετες
CL2014003325A1 (es) Compuestos derivados de difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos, inhibidores de bace 1; composicion farmaceutica; y su uso en el tratamiento de enfermedades con niveles elevados de beta-amiloide, tal como la enfermedad de alzheimer
UA117154C2 (uk) Антагоністи s1p3
MX2014014308A (es) Pirrolidino heterociclos.
IN2014DN11112A (tr)
EA201700356A1 (ru) Новые циклопропанбензофуранилпиридопиразиндионы
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
UY35253A (es) Compuesto farmacéutico para la prevención y el tratamiento de un trastorno o una enfermedad cogniti vos, neurodegenerativos o neuronales
EA201591150A1 (ru) Твердая единая форма с высоким содержанием фексофенадина и способ ее получения
MD20140122A2 (ro) Procedee de producere a clorhidratului de anamorelin cu un conţinut controlat de clorură
TR201908151T4 (tr) İzoindolin türevleri.
MX2018004696A (es) Analogos de epotilona, metodos de sintesis, metodos de tratamiento y conjugados con farmacos de los mismos.
EA201791354A2 (ru) Препараты производных пиримидиндиона
EA201500209A1 (ru) Четвертичные соли пиперидиния
PH12018500014A1 (en) Total synthesis of shishijimicin a and analogs thereof